189 related articles for article (PubMed ID: 24304921)
1. Health state utilities in patients with diabetic retinopathy, diabetic macular oedema and age-related macular degeneration: a systematic review.
Poku E; Brazier J; Carlton J; Ferreira A
BMC Ophthalmol; 2013 Dec; 13():74. PubMed ID: 24304921
[TBL] [Abstract][Full Text] [Related]
2. Evaluating the Relationship Between Visual Acuity and Utilities in Patients With Diabetic Macular Edema Enrolled in Intravitreal Aflibercept Studies.
Brazier J; Muston D; Konwea H; Power GS; Barzey V; Lloyd A; Sowade O; Vitti B; Gerlinger C; Roberts J
Invest Ophthalmol Vis Sci; 2017 Sep; 58(11):4818-4825. PubMed ID: 28973328
[TBL] [Abstract][Full Text] [Related]
3. The impact of age-related macular degeneration on health status utility values.
Espallargues M; Czoski-Murray CJ; Bansback NJ; Carlton J; Lewis GM; Hughes LA; Brand CS; Brazier JE
Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4016-23. PubMed ID: 16249475
[TBL] [Abstract][Full Text] [Related]
4. A systematic literature review of utility weights in wet age-related macular degeneration.
Pearson I; Rycroft C; Irving A; Ainsworth C; Wittrup-Jensen K
J Med Econ; 2013 Nov; 16(11):1307-16. PubMed ID: 24004384
[TBL] [Abstract][Full Text] [Related]
5. Validity of EuroQOL-5D, time trade-off, and standard gamble for age-related macular degeneration in the Singapore population.
Au Eong KG; Chan EW; Luo N; Wong SH; Tan NW; Lim TH; Wagle AM
Eye (Lond); 2012 Mar; 26(3):379-88. PubMed ID: 22222257
[TBL] [Abstract][Full Text] [Related]
6. Systematic review of health state utility values in metastatic non-small cell lung cancer with a focus on previously treated patients.
Paracha N; Abdulla A; MacGilchrist KS
Health Qual Life Outcomes; 2018 Sep; 16(1):179. PubMed ID: 30208899
[TBL] [Abstract][Full Text] [Related]
7. Anti-vascular endothelial growth factor for diabetic macular oedema: a network meta-analysis.
Virgili G; Parravano M; Evans JR; Gordon I; Lucenteforte E
Cochrane Database Syst Rev; 2017 Jun; 6(6):CD007419. PubMed ID: 28639415
[TBL] [Abstract][Full Text] [Related]
8. Anti-vascular endothelial growth factor for diabetic macular oedema: a network meta-analysis.
Virgili G; Parravano M; Evans JR; Gordon I; Lucenteforte E
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD007419. PubMed ID: 30325017
[TBL] [Abstract][Full Text] [Related]
9. Cost effectiveness of pegaptanib for the treatment of age-related macular degeneration in the UK.
Wolowacz SE; Roskell N; Kelly S; Maciver FM; Brand CS
Pharmacoeconomics; 2007; 25(10):863-79. PubMed ID: 17887807
[TBL] [Abstract][Full Text] [Related]
10. A systematic literature review of health state utility values in head and neck cancer.
Meregaglia M; Cairns J
Health Qual Life Outcomes; 2017 Sep; 15(1):174. PubMed ID: 28865475
[TBL] [Abstract][Full Text] [Related]
11. The use of weighted health-related Quality of Life scores in people with diabetic macular oedema at baseline in a randomized clinical trial.
Scanlon PH; Loftus J; Starita C; Stratton IM
Diabet Med; 2015 Jan; 32(1):97-101. PubMed ID: 25251842
[TBL] [Abstract][Full Text] [Related]
12. Health state utility values for diabetic retinopathy: protocol for a systematic review and meta-analysis.
Sampson CJ; Tosh JC; Cheyne CP; Broadbent D; James M
Syst Rev; 2015 Feb; 4():15. PubMed ID: 25875206
[TBL] [Abstract][Full Text] [Related]
13. Quality of life with visual acuity loss from diabetic retinopathy and age-related macular degeneration.
Brown MM; Brown GC; Sharma S; Landy J; Bakal J
Arch Ophthalmol; 2002 Apr; 120(4):481-4. PubMed ID: 11934322
[TBL] [Abstract][Full Text] [Related]
14. Health state utility values in major depressive disorder treated with pharmacological interventions: a systematic literature review.
Brockbank J; Krause T; Moss E; Pedersen AM; Mørup MF; Ahdesmäki O; Vaughan J; Brodtkorb TH
Health Qual Life Outcomes; 2021 Mar; 19(1):94. PubMed ID: 33736649
[TBL] [Abstract][Full Text] [Related]
15. Standard threshold laser versus subthreshold micropulse laser for adults with diabetic macular oedema: the DIAMONDS non-inferiority RCT.
Lois N; Campbell C; Waugh N; Azuara-Blanco A; Maredza M; Mistry H; McAuley D; Acharya N; Aslam TM; Bailey C; Chong V; Downey L; Eleftheriadis H; Fatum S; George S; Ghanchi F; Groppe M; Hamilton R; Menon G; Saad A; Sivaprasad S; Shiew M; Steel DH; Talks JS; Doherty P; McDowell C; Clarke M
Health Technol Assess; 2022 Dec; 26(50):1-86. PubMed ID: 36541393
[TBL] [Abstract][Full Text] [Related]
16. Non-invasive testing for early detection of neovascular macular degeneration in unaffected second eyes of older adults: EDNA diagnostic accuracy study.
Banister K; Cook JA; Scotland G; Azuara-Blanco A; Goulão B; Heimann H; Hernández R; Hogg R; Kennedy C; Sivaprasad S; Ramsay C; Chakravarthy U
Health Technol Assess; 2022 Jan; 26(8):1-142. PubMed ID: 35119357
[TBL] [Abstract][Full Text] [Related]
17. Real-World Effectiveness and Real-World Cost-Effectiveness of Intravitreal Aflibercept and Intravitreal Ranibizumab in Neovascular Age-Related Macular Degeneration: Systematic Review and Meta-Analysis of Real-World Studies.
Carrasco J; Pietsch GA; Nicolas MP; Koerber C; Bennison C; Yoon J
Adv Ther; 2020 Jan; 37(1):300-315. PubMed ID: 31728825
[TBL] [Abstract][Full Text] [Related]
18. Assessing disutility associated with diabetic retinopathy, diabetic macular oedema and associated visual impairment using the Vision and Quality of Life Index.
Fenwick EK; Xie J; Pesudovs K; Ratcliffe J; Chiang PP; Finger RP; Lamoureux EL
Clin Exp Optom; 2012 May; 95(3):362-70. PubMed ID: 22537275
[TBL] [Abstract][Full Text] [Related]
19. Optical coherence tomography (OCT) for detection of macular oedema in patients with diabetic retinopathy.
Virgili G; Menchini F; Casazza G; Hogg R; Das RR; Wang X; Michelessi M
Cochrane Database Syst Rev; 2015 Jan; 1(1):CD008081. PubMed ID: 25564068
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
